logo
Camfil APC Publishes Comprehensive Guide on Pharmaceutical Dust Collection Strategies for Oral Solid Dose Manufacturing

Camfil APC Publishes Comprehensive Guide on Pharmaceutical Dust Collection Strategies for Oral Solid Dose Manufacturing

06/06/2025, Jonesboro, AR // KISS PR Brand Story PressWire //
Camfil APC, a leading manufacturer of industrial dust collectors, today announced the publication of a comprehensive technical guide addressing dust collection strategies for oral solid dose (OSD) pharmaceutical manufacturing. The resource, Pharmaceutical Dust Collection: Strategies for Oral Solid Dose Pharmaceutical Manufacturing, provides industry professionals with essential insights into managing potent compound containment, regulatory compliance, and operational efficiency through advanced air filtration technologies.
Addressing Critical Industry Challenges
The pharmaceutical manufacturing industry faces complex challenges in maintaining worker safety while ensuring product quality and regulatory compliance. This new guide specifically addresses the unique air quality management requirements of OSD production, where exposure to potent, toxic, and allergenic dusts presents significant risks to both personnel and product integrity.
'OSD pharmaceutical manufacturers require specialized dust collection solutions that go beyond standard industrial applications,' said Tony Galvin, Pharmaceutical Segment Manager, at Camfil APC. 'Our new guide provides the technical depth and practical guidance that process engineers, facility managers, and safety professionals need to implement effective containment strategies.'
Comprehensive Technical Coverage
The guide covers essential aspects of pharmaceutical OSD dust collection implementation, including:
Advanced Filtration Solutions for Pharmaceutical Applications
The guide features information on Camfil APC's pharmaceutical OSD dust collection solutions, including:
Each solution incorporates advanced HEPA filtration technology and specialized containment features designed to meet the stringent requirements of OSD pharmaceutical production environments.
Industry Expert Insights
The guide draws upon extensive experience in pharmaceutical manufacturing applications, providing real-world case studies and implementation examples. Content addresses the specific concerns of cross-functional teams typically involved in dust collection system selection, including process engineers, facilities managers, health and safety professionals, quality assurance teams, and maintenance personnel.
'Effective dust collection in pharmaceutical OSD manufacturing requires understanding both the technical requirements and the operational realities of production environments,' noted Tony Galvin, Pharmaceutical Segment Manager, at Camfil APC. 'This guide bridges that gap by providing practical implementation strategies backed by proven engineering principles.'
Supporting Pharmaceutical Industry Innovation
The guide reflects Camfil APC's ongoing commitment to supporting OSD pharmaceutical manufacturing excellence through advanced dust collection and air filtration technology. As the industry continues to evolve with new compounds, production methods, and regulatory requirements, effective dust collection strategies remain essential for maintaining competitive operations while ensuring worker safety and product quality.
Technical Resource Availability
The complete pharmaceutical OSD dust collection strategies guide is available immediately through Camfil APC's website at camfilapc.com/blog/pharmaceutical-dust-collection-strategies-for-oral-solid-dose-pharmaceutical-manufacturing/.
About Camfil APC
Camfil APC is a leading manufacturer of dust, mist, and fume collection equipment for industrial applications. With decades of experience in air filtration technology, the company provides engineered solutions for challenging industrial environments, including pharmaceutical manufacturing, food processing, metalworking, and chemical production. Camfil APC's comprehensive product portfolio includes dust collectors, replacement filters, and complete system integration services.
The company maintains manufacturing facilities in Jonesboro, Arkansas, and provides technical support, installation, and maintenance services across North America. Camfil APC is part of the global Camfil Group, recognized worldwide for innovation in air filtration technology and commitment to clean air solutions.
For more information about Camfil APC's OSD pharmaceutical dust collection solutions, visit https://camfilapc.com/applications/pharmaceutical/.
Media Contact:
Lisa Goetz
Schubert b2b
1-610-269-2100 x244
[email protected]
Technical Contact:
Tony Galvin
Pharmaceutical Segment Manager
Camfil APC
1-612-865-9377
[email protected]
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump eyes US government stakes in other chip makers that received CHIPS Act funds, sources say
Trump eyes US government stakes in other chip makers that received CHIPS Act funds, sources say

Yahoo

time25 minutes ago

  • Yahoo

Trump eyes US government stakes in other chip makers that received CHIPS Act funds, sources say

By Nandita Bose and Max A. Cherney WASHINGTON (Reuters) -U.S. Commerce Secretary Howard Lutnick is looking into the federal government taking equity stakes in computer chip manufacturers that receive CHIPS Act funding to build factories in the country, two sources said. Expanding on a plan to receive an equity stake in Intel in exchange for cash grants, a White House official and a person familiar with the situation said Lutnick is exploring how the U.S. can receive equity stakes in exchange for CHIPS Act funding for companies such as Micron, Taiwan Semiconductor Manufacturing Co and Samsung. Much of the funding has not yet been dispersed. Aside from Intel, memory chipmaker Micron is the biggest U.S. recipient of CHIPS Act cash. TSMC declined comment. Micron, Samsung and the White House did not respond to requests for comment. White House press secretary Karoline Leavitt confirmed on Tuesday that Lutnick was working on a deal with Intel to take a 10% government stake. "The president wants to put America's needs first, both from a national security and economic perspective, and it's a creative idea that has never been done before," she told reporters. While Lutnick said earlier on CNBC that the U.S. does not want to tell Intel how to run its operations, any investment would be unprecedented and ramps up a new era of U.S. influence on the big companies. In the past, the U.S. has taken stakes in companies to provide cash and build confidence in times of economic upheaval and uncertainty. In a similar move earlier this year, Trump approved Nippon Steel's purchase of U.S. Steel after being promised a "golden share" that would prevent the companies from reducing or delaying promised investments, transferring production or jobs outside the U.S., or closing or idling plants before certain time frames, without the president's consent. The two sources said Treasury Secretary Scott Bessent is also involved in the CHIPS Act discussions, but that Lutnick is driving the process. The Commerce Department oversees the $52.7 billion CHIPS Act, formally known as the CHIPS and Science Act. The act provides funding for research and grants for building chip plants in the U.S. Lutnick has been pushing the equity idea, the sources said, adding that Trump likes the idea. The U.S. Commerce Department late last year finalized subsidies of $4.75 billion for Samsung, $6.2 billion for Micron and $6.6 billion for TSMC to produce semiconductors in the U.S. In June, Lutnick said the department was re-negotiating some of former President Joe Biden's grants to semiconductor firms, calling them "overly generous". He noted at the time that Micron offered to increase its spending on chip plants in the U.S.

Vantage Data Centers plans $25 billion AI campus in Texas
Vantage Data Centers plans $25 billion AI campus in Texas

Yahoo

time25 minutes ago

  • Yahoo

Vantage Data Centers plans $25 billion AI campus in Texas

(Reuters) -Vantage Data Centers said on Tuesday it would spend more than $25 billion to build a 1,200-acre data center campus in Shackelford County, Texas, as surging demand for artificial intelligence infrastructure fuels mega-scale developments. Backed by private equity firm Silver Lake and asset manager DigitalBridge, Vantage said the 1.4-gigawatt campus, dubbed "Frontier", is the largest in its global portfolio. Chatbots such as OpenAI's ChatGPT and Google's Gemini need massive compute, prompting demand for purpose-built data centers. These facilities are costly as they require cutting-edge chips, servers, adequate power and cooling solutions. Companies including Alphabet, Microsoft and Meta Platforms are committing billions of dollars to expand and create their data center facilities. Vantage says the construction of the campus has begun, which will be home to 10 data centers and support ultra-high-density racks exceeding 250 kilowatts each. The first building is due in the second half of next year. Silver Lake was a founding investor in Vantage in 2010. Vantage CEO Sureel Choksi joined the company from Silver Lake in 2013. After exiting Vantage in 2017, Silver Lake said it was invited back on a proprietary basis in 2023 to support capital raising and co-lead a $9.2 billion equity financing with DigitalBridge in 2024.

It's Been The 'Summer of Stablecoins,' Goldman Says. Will Traditional Finance Be Upended?
It's Been The 'Summer of Stablecoins,' Goldman Says. Will Traditional Finance Be Upended?

Yahoo

time25 minutes ago

  • Yahoo

It's Been The 'Summer of Stablecoins,' Goldman Says. Will Traditional Finance Be Upended?

Key Takeaways The roughly $270 billion global stablecoins market stands to disrupt the traditional financial services industry, but to what degree remains an "open question," according to a recent Goldman Sachs report. Goldman analysts say that concerns about the potential disintermediation of companies that provide payment and remittance services are overdone. The firm sees Circle's USDC taking greater share of the stablecoin market at the expense of Tether's offshore USDT. The first federal regulatory system signed into law brought about something of a summer awakening for stablecoins. Whether the roughly $270 billion global market in tokens pegged to real-world currencies will grow to trillions, and eat into traditional financial services industries, remains to be seen. Stablecoins, now predominantly used for crypto trading and for dollar access outside of the U.S., have been prophesied to replace and modernize legacy systems with blockchain efficiency. However, total disruption is unlikely, Goldman Sachs Research said in a report published Tuesday. Analysts including Will Nance and James Yaro wrote that stablecoin benefits will accrue to the infrastructure layer of the financial sector, particularly in interbank payments, as well as settlements in capital markets, complex, and cross-border transactions. However, they see "limited threats" to payments services, including the consumer card ecosystem, and that their collective underperformance presents an opportunity to buy. Visa (V) and Mastercard (MA) are less rivals and more"likely to play a large role in facilitating stablecoin payments at scale in a consumer context," the report said. Also, risk to remittance players, including Remitly (RELY) and Western Union (WU), are exaggerated, according to the report. Goldman thinks GENIUS Act-compliant stablecoins such as Circle's (CRCL) USDC will take greater share at the expense of USDT, Tether's offshore stablecoin. The firm sees $77 billion of growth in USDC, or an estimated compound annual growth rate of 40% from 2024 to 2027. Tether's USDT is the world's largest stablecoin, with a $165 billion market cap, compared to Circle USDC's $66 billion, according to research platform However, with Circle's elevated valuation after its blockbuster IPO earlier this year, Goldman favors Robinhood (HOOD) for its continued innovation in crypto. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store